中国医药
(600056)
| 流通市值：152.82亿 | | | 总市值：152.88亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,769,756,319.52 | 4,214,785,882.65 | 2,706,629,673.57 | 3,209,712,856.96 |
| 衍生金融资产 | - | - | - | 0 |
| 应收票据及应收账款 | 14,841,460,587.84 | 13,294,963,122.6 | 15,801,408,852.22 | 15,918,672,982.02 |
| 其中：应收票据 | 537,392,004.84 | 543,977,467.35 | 445,529,351.94 | 440,364,907.82 |
| 应收账款 | 14,304,068,583 | 12,750,985,655.25 | 15,355,879,500.28 | 15,478,308,074.2 |
| 应收款项融资 | 234,112,430.04 | 387,121,445.84 | 253,766,809.94 | 329,892,667.56 |
| 预付款项 | 1,063,401,420.24 | 726,118,945.07 | 1,105,934,342.75 | 1,047,389,809.2 |
| 其他应收款合计 | 1,582,067,947.08 | 1,555,649,821.22 | 1,748,660,144.59 | 1,737,993,667.91 |
| 存货 | 5,769,273,940.01 | 5,732,324,674.53 | 6,830,209,470.71 | 5,884,057,908.46 |
| 合同资产 | 84,287,312.19 | 56,619,943.98 | 29,309,592.85 | 25,852,052.78 |
| 一年内到期的非流动资产 | 44,210,847.2 | 46,448,446.08 | 53,405,277.74 | 53,405,277.74 |
| 其他流动资产 | 270,847,841.76 | 227,970,224.55 | 349,593,832.61 | 484,845,414.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 26,788,148,856.29 | 26,370,732,716.93 | 28,878,917,996.98 | 28,691,822,636.82 |
| 非流动资产: | | | | |
| 长期应收款 | 14,019,004.24 | 10,623,788.41 | 18,326,038.5 | 18,278,491.68 |
| 长期股权投资 | 2,709,421,496.51 | 2,693,259,296.51 | 2,684,276,717.03 | 2,672,276,717.03 |
| 其他权益工具投资 | 47,892,962.15 | 47,168,046.76 | 47,085,401.26 | 47,085,401.26 |
| 投资性房地产 | 91,807,660.57 | 94,627,563.46 | 88,082,460.82 | 87,802,317.23 |
| 固定资产 | 2,283,830,265.74 | 2,248,464,376.52 | 2,260,725,729.05 | 2,273,543,912.05 |
| 在建工程 | 201,915,499.24 | 257,610,059.01 | 236,704,579.8 | 202,971,372.24 |
| 使用权资产 | 281,931,199.75 | 302,784,180.61 | 293,569,750.42 | 311,127,532.55 |
| 无形资产 | 671,259,331.23 | 678,237,528.42 | 614,922,727.48 | 607,405,514.1 |
| 开发支出 | 485,688,685.8 | 476,017,072.6 | 530,291,755.8 | 488,112,428.14 |
| 商誉 | 996,062,765.04 | 996,062,765.04 | 1,123,822,084.62 | 1,123,822,084.62 |
| 长期待摊费用 | 147,407,867.8 | 152,351,205.64 | 156,051,716.46 | 151,580,366.78 |
| 递延所得税资产 | 711,448,406.67 | 693,408,716.09 | 675,571,807.74 | 670,708,563.35 |
| 其他非流动资产 | 260,221,851.02 | 259,711,597.54 | 269,527,854.39 | 272,858,712.3 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,902,906,995.76 | 8,910,326,196.61 | 8,998,958,623.37 | 8,927,573,413.33 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 35,691,055,852.05 | 35,281,058,913.54 | 37,877,876,620.35 | 37,619,396,050.15 |
| 流动负债: | | | | |
| 短期借款 | 4,130,903,346.39 | 4,004,522,699.55 | 3,584,066,818.33 | 3,315,455,015.06 |
| 衍生金融负债 | - | 154,794.37 | - | - |
| 应付票据及应付账款 | 8,766,519,921.33 | 8,351,558,716.8 | 10,443,355,990.58 | 9,793,053,959.74 |
| 其中：应付票据 | 1,458,044,421.81 | 1,306,360,298 | 1,263,266,418.7 | 1,219,357,238.64 |
| 应付账款 | 7,308,475,499.52 | 7,045,198,418.8 | 9,180,089,571.88 | 8,573,696,721.1 |
| 预收款项 | 2,501,360.16 | 1,351,471.78 | 6,358,640.72 | 3,973,089.51 |
| 合同负债 | 1,145,083,584.96 | 1,086,941,691.7 | 1,239,677,056.4 | 1,117,626,966.58 |
| 应付职工薪酬 | 182,063,367.92 | 256,044,260.24 | 258,201,322.96 | 245,429,893.35 |
| 应交税费 | 199,216,880.06 | 192,553,034.55 | 132,509,208.14 | 147,015,862.52 |
| 其他应付款合计 | 2,532,377,049.31 | 2,345,517,236.08 | 3,473,041,559.38 | 3,844,183,702.2 |
| 应付股利 | 2,440,527.59 | 5,435,337.53 | 19,508,671.31 | 141,792,194.89 |
| 一年内到期的非流动负债 | 93,378,155.08 | 700,255,146.13 | 550,173,018.41 | 592,831,742.09 |
| 其他流动负债 | 171,714,473.17 | 237,864,486.25 | 224,748,238.51 | 233,229,961.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 17,223,758,138.38 | 17,176,763,537.45 | 19,912,131,853.43 | 19,292,800,192.75 |
| 非流动负债: | | | | |
| 长期借款 | 1,894,256,829.3 | 1,553,356,829.3 | 1,643,856,829.3 | 1,928,356,829.3 |
| 租赁负债 | 207,444,786.04 | 187,914,681 | 235,187,992.1 | 252,951,117.88 |
| 长期应付款 | 1,889,671,029.18 | 2,126,159,509.38 | 1,899,394,225.31 | 1,947,288,795.31 |
| 长期应付职工薪酬 | 16,599,626.18 | 16,448,768.61 | 16,625,799.57 | 16,625,799.57 |
| 预计负债 | - | - | 1,672,226.55 | 131,496,414.16 |
| 递延收益 | 63,751,643.56 | 65,383,338.12 | 66,569,124.24 | 66,996,962.36 |
| 递延所得税负债 | 56,258,529.53 | 44,201,985.72 | 13,684,654.69 | 14,134,215.64 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,127,982,443.79 | 3,993,465,112.13 | 3,876,990,851.76 | 4,357,850,134.22 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 21,351,740,582.17 | 21,170,228,649.58 | 23,789,122,705.19 | 23,650,650,326.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 2,084,126,755.08 | 2,084,126,755.08 | 2,012,303,239.72 | 2,012,303,239.72 |
| 其他综合收益 | 1,977,145.84 | 1,092,168.55 | -2,069,120.46 | 18,981.04 |
| 盈余公积 | 613,257,225.23 | 613,257,225.23 | 603,726,551.38 | 603,726,551.38 |
| 未分配利润 | 7,792,539,328.46 | 7,626,160,092.44 | 7,547,371,404.8 | 7,457,862,542.89 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,987,780,202.61 | 11,820,515,989.3 | 11,657,211,823.44 | 11,569,791,063.03 |
| 少数股东权益 | 2,351,535,067.27 | 2,290,314,274.66 | 2,431,542,091.72 | 2,398,954,660.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 14,339,315,269.88 | 14,110,830,263.96 | 14,088,753,915.16 | 13,968,745,723.18 |
| 负债和股东权益合计 | 35,691,055,852.05 | 35,281,058,913.54 | 37,877,876,620.35 | 37,619,396,050.15 |
| 公告日期 | 2025-04-30 | 2025-04-26 | 2024-10-26 | 2024-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |